World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
9226
World Ranking
3998
National Ranking
156

Harry Dolstra publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Harry Dolstra sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Harry Dolstra D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Harry Dolstra sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Harry Dolstra is affiliated with Radboud University in the Netherlands and has made contributions in the fields of medicine, immunology, and microbiology. Their research primarily spans immunology, oncology, hematology, physiology, and molecular biology. The work frequently addresses topics such as CAR-T cell therapy research, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy and immune responses, hematopoietic stem cell transplantation, reproductive system and pregnancy, and immune cells in cancer.

The research output includes numerous publications, with a notable presence in several scientific journals. The most frequent publication venues for Dolstra's work include:

  • Bone Marrow Transplantation
  • Cytotherapy
  • Cancer Immunology Immunotherapy
  • Leukemia Research
  • OncoImmunology

Dolstra's recent papers cover topics related to hematopoietic cell transplantation, cellular therapies, and immune cell cytotoxicity. Selected recent publications include:

  • "Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years" (2021), Bone Marrow Transplantation
  • "Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022" (2022), Bone Marrow Transplantation
  • "Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity" (2021), Nature Communications
  • "The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy" (2020), Bone Marrow Transplantation
  • "The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus" (2020), Bone Marrow Transplantation

Collaboration is a significant part of Dolstra's work, with several frequent co-authors, including:

  • Willemijn Hobo
  • Joop H. Jansen
  • Paul K.J.D. de Jonge
  • Nicolaas Schaap
  • Anniek B. van der Waart

Best Publications

  • Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Induction of myelodysplasia by myeloid-derived suppressor cells.

    Xianghong Chen;Erika A. Eksioglu;Junmin Zhou;Ling Zhang

  • A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia

    H. Dolstra;H. Fredrix;F.M.H.M. Maas;P.G. Coulie

  • Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

    Sandra Heskamp;Willemijn Hobo;Janneke D.M. Molkenboer-Kuenen;Daniel Olive

  • Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

    Jan Spanholtz;Frank Preijers;Marleen Tordoir;Carel Trilsbeek

  • Comprehensive Phenotyping of T Cells Using Flow Cytometry.

    Charlotte M. Mousset;Willemijn Hobo;Rob Woestenenk;Frank Preijers

  • Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients

    Harry Dolstra;Mieke W.H. Roeven;Jan Spanholtz;Basav N. Hangalapura

  • Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity.

    Bettina Weigelin;Annemieke Th den Boer;Esther Wagena;Kelly Broen

  • PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

    Wieger J. Norde;Frans Maas;Willemijn Hobo;Alan Korman

  • The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.

    Per Ljungman;Per Ljungman;Malgorzata Mikulska;Rafael de la Camara;Grzegorz W Basak

  • High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

    Jan Spanholtz;Marleen Tordoir;Diana Eissens;Frank Preijers

  • siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells

    Willemijn Hobo;Frans Maas;Niken Adisty;Theo de Witte

  • The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.

    Jakob R. Passweg;Helen Baldomero;Christian Chabannon;Grzegorz W. Basak

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

    Björn de Rijke;Agnes van Horssen-Zoetbrood;Jeffrey M. Beekman;Britt Otterud

  • Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

    Florian Wimmers;Florian Wimmers;Nikita Subedi;Nicole van Buuringen;Daan Heister

  • Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy

    Anniek B. van der Waart;Noortje M. P. van de Weem;Frans Maas;Cynthia S. M. Kramer

  • Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.

    H. Dolstra;H. Fredrix;F.W.M.B. Preijers;E. Goulmy

  • Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms.

    F.M.H.M. Maas;N.P.M. Schaap;S.M.H. Kolen;A. Zoetbrood

  • Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

    Willemijn Hobo;Tatiana I. Novobrantseva;Hanny Fredrix;Jamie Wong

  • Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice

    Jeannette Cany;Anniek B van der Waart;Marleen Tordoir;Gerben M. Franssen

Frequent Co-Authors

Joop H. Jansen
Joop H. Jansen Radboud University
Theo de Witte
Theo de Witte Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University
J.H. Frederik Falkenburg
J.H. Frederik Falkenburg Leiden University Medical Center
Leon F.A.G. Massuger
Leon F.A.G. Massuger Radboud University
Otto C. Boerman
Otto C. Boerman Radboud University
Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
Peter Friedl
Peter Friedl Radboud University Medical Center
Daniel Olive
Daniel Olive Aix-Marseille University
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding career options in healthcare often involves exploring related nursing programs. Those seeking an entry point into healthcare might consider the which lpn programs are easiest to get into, as Licensed Practical Nurse roles offer quick transitions into patient care with manageable program requirements.

Advancing beyond LPN, many pursue family nurse practitioner roles. Identifying the easiest fnp program can help streamline the process, enabling students to gain advanced practice licenses more efficiently while preparing for diverse clinical settings.

For those interested in mental health, psychiatric nursing is a fast-growing field where programs offering strong clinical placements are critical. Exploring the best psychiatric mental health nurse practitioner programs online ensures practical experience in real-world settings, a key to successful licensure and career readiness.

Cost is also a significant factor in choosing a program. Many students benefit from researching affordable pmhnp programs, which minimize financial barriers while maintaining quality education, supporting a sustainable path towards specialized Immunology-related healthcare roles.

Best Scientists Citing Harry Dolstra

Trending Scientists

Recently Published Articles